JXR Adds 1.58 Million Shares to Treasury, Lifting Buy-back Tally to 63.51 Million under 2026 Mandate

Bulletin Express10-20 19:40

On 20 October 2026, Jinxin Fertility Group Limited (JXR) repurchased 1.58 million ordinary shares on the Hong Kong Stock Exchange at prices ranging between HKD 2.18 and HKD 2.24 per share. The buy-back cost HKD 3.51 million in aggregate and was executed under the general mandate granted on 25 June 2026.

Following the transaction, JXR’s treasury‐share balance rose to 50.97 million, equivalent to 1.88% of the company’s 2.71 billion total issued shares. The outstanding issued share capital (excluding treasury shares) now stands at 2.65 billion. The latest purchase represents 0.06% of that figure.

To date, JXR has repurchased 63.51 million shares—2.42% of the company’s share base when the mandate was approved—against a maximum authorised limit of 262.51 million shares.

In addition, 92.47 million shares (3.48% of current outstanding shares) acquired between March and August 2026 remain pending cancellation. Under Hong Kong Listing Rules, the company is restricted from issuing new shares or disposing of treasury shares until 19 November 2026.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment